Boldenone
| Clinical data | |
|---|---|
| Other names | Δ1-Testosterone; 1-Dehydrotestosterone; RU-18761; Androsta-1,4-dien-17β-ol-3-one | 
| AHFS/Drugs.com | International Drug Names | 
| Pregnancy category | |
| Routes of administration | Intramuscular injection | 
| Drug class | Androgen; Anabolic steroid | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Elimination half-life | Intramuscular: 14 days (as boldenone undecylenate) | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.533 | 
| Chemical and physical data | |
| Formula | C19H26O2 | 
| Molar mass | 286.415 g·mol−1 | 
| 3D model (JSmol) | |
| Melting point | 165 °C (329 °F) | 
| 
 | |
| 
 | |
| (what is this?) (verify) | |
Boldenone (developmental code name RU-18761), is a naturally occurring anabolic–androgenic steroid (AAS) and the 1(2)-dehydrogenated analogue of testosterone. Boldenone itself has never been marketed; as a pharmaceutical drug, it is used as boldenone undecylenate, the undecylenate ester.